KEGG   DRUG: Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabineHelp
Entry
D10571            Mixture   Drug                                   

Name
Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabine;
Complera (TN);
Eviplera (TN)
Product
Component
Rilpivirine hydrochloride [DR:D09958], Tenofovir disoproxil fumarate [DR:D01982], Emtricitabine [DR:D01199]
Remark
Therapeutic category: 6250
ATC code: J05AR08
Product: D10571<JP/US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Comment
Rilpivirine is primarily metabolized by CYP3A.
Metabolism
Enzyme: CYP3A [HSA:1576 1577 1551]
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR08 Emtricitabine, tenofovir disoproxil and rilpivirine
      D10571  Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabine <JP/US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Agents, Other
   Emtricitabine/ Rilpivirine / Tenofovir Disoproxil Fumarate
    D10571  Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabine
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D10571  Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabine
Antiinfectives [br08350.html]
 Antivirals
  D10571
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10571
BRITE hierarchy
Other DBs
PubChem: 254741533
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system